Repository logo
 
Publication

Endovascular Treatment for Anterior Circulation Large-Vessel Occlusion Ischemic Stroke with Low ASPECTS: a Systematic Review and Meta-Analysis

dc.contributor.authorSafouris, A
dc.contributor.authorPalaiodimou, L
dc.contributor.authorSzikora, I
dc.contributor.authorKargiotis, O
dc.contributor.authorMagoufis, G
dc.contributor.authorPsychogios, K
dc.contributor.authorParaskevas, G
dc.contributor.authorSpiliopoulos, S
dc.contributor.authorBrountzos, E
dc.contributor.authorNardai, S
dc.contributor.authorGoyal, N
dc.contributor.authorAguiar de Sousa, D
dc.contributor.authorStrbian, D
dc.contributor.authorCaso, V
dc.contributor.authorAlexandrov, A
dc.contributor.authorTsivgoulis, G
dc.date.accessioned2023-08-25T14:45:04Z
dc.date.available2023-08-25T14:45:04Z
dc.date.issued2022-11
dc.description.abstractBackground: Endovascular treatment (EVT) for acute ischemic stroke (AIS) patients presenting with Alberta Stroke Program Early CT Score (ASPECTS) 0-5 has not yet proven safe and effective by clinical trials. Objectives: The aim of the study was to assess whether EVT in AIS patients presenting with low ASPECTS is beneficial. Design: Systematic review and meta-analysis of available studies in accordance with the PRISMA statement. Data sources and methods: We have searched MEDLINE, the Cochrane Central Register of Controlled Trials, and reference lists of articles published until 28 May 2022 with the aim to calculate (1) modified Rankin scale (mRS) score 0-3 at 3 months, (2) mRS score 0-2 at 3 months, (3) symptomatic intracranial hemorrhage (sICH), and (3) mortality at 3 months. Results: Overall, 24 eligible studies were included in the meta-analysis, comprising a total of 2539 AIS patients with ASPECTS 0-5 treated with EVT. The pooled proportion of EVT-treated patients achieving mRS 0-3 at 3 months was calculated at 38.4%. The pooled proportion of EVT-treated patients achieving mRS 0-2 at 3 months was 25.7%. Regarding safety outcomes, sICH occurred in 12.8% of patients. The 3-month pooled mortality was 30%. In pairwise meta-analysis, patients treated with EVT had a higher likelihood of achieving mRS 0-3 at 3 months compared with patients treated with best medical therapy (BMT, OR: 2.41). sICH occurred more frequently in EVT-treated patients compared with the BMT-treated patients (OR: 2.30). Mortality at 3 months was not different between the two treatment groups (OR: 0.71). Conclusion: EVT may be beneficial for AIS patients with low baseline ASPECTS despite an increased risk for sICH. Further data from randomized-controlled clinical trials are needed to elucidate the role of EVT in this subgroup of AIS patients. Registration: The protocol has been registered in the International Prospective Register of Ongoing Systematic Reviews PROSPERO; Registration Number: CRD42022334417.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTher Adv Neurol Disord . 2022 Nov 29;15:17562864221139632.pt_PT
dc.identifier.doi10.1177/17562864221139632pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4661
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSagept_PT
dc.subjectHSJ NEUpt_PT
dc.subjectASPECTSpt_PT
dc.subjectEndovascular Treatmentpt_PT
dc.subjectLarge-Vessel Occlusionpt_PT
dc.subjectModified Rankin Scalept_PT
dc.subjectSymptomatic Intracranial Hemorrhagept_PT
dc.subjectMortalitypt_PT
dc.subjectStrokept_PT
dc.titleEndovascular Treatment for Anterior Circulation Large-Vessel Occlusion Ischemic Stroke with Low ASPECTS: a Systematic Review and Meta-Analysispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPage175628642211396pt_PT
oaire.citation.titleTherapeutic Advances in Neurological Disorderspt_PT
oaire.citation.volume15pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ther Adv Neurol Disord.pdf
Size:
1.69 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections